SYDNEY; A Research report, published in the PLOS Medicine, stressed on the need to invest in new vaccine designs to keep pace with emerging Covid variants. The study sheds light that body's natural immune response following Covid infection is sustained for up to seven months, but these antibodies are not adequate against contemporary variants of the virus, finds a study suggesting the significance of vaccines against the infectious disease.

Researchers analysed the serum of 233 individuals diagnosed with Covid-19 over seven months and found that the level of immunity over time is dependent on disease severity and the viral variant. Further, the antibodies developed during the first wave also had reduced effectiveness against six variants, ranging from those observed in the second wave in Australia through to three variants of concern that have driven the global pandemic in the UK, Brazil and South Africa.

"We can learn a great deal from these people who were infected in the first wave in Australia as they were infected with the same variant that our current vaccines are based on," "While the approved vaccines are showing good responses, our study highlights the importance of continued vaccine development, especially taking into account the differences in variants," said Fabienne Brilot, Associate Professor at the University of Sydney. "We can learn a great deal from these people who were infected in the first wave in Australia as they were infected with the same variant that our current vaccines are based on," Brilot added.

Vaccination exercise: India's Covid inoculation coverage surpasses 35.75 Cr.

Covid-19 Third-wave likely to hit India in August: SBI Research

Study Synopsis on Malnutrition among under-five children in India